Egypt Neurology Devices Investment Opportunities, Analysis and Forecasts to 2017

Global Markets Direct, April 2011, Pages: 108

Egypt Neurology Devices Investment Opportunities, Analysis and Forecasts to 2017

Summary

“Egypt Neurology Devices Investment Opportunities, Analysis and Forecasts to 2017”, a new report by Global Markets Direct, provides key market data on the Egypt Neurology Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within five market categories – Neurostimulation Devices, Neurological Diagnostic Equipment, Interventional Neurology, CSF Management and Neurosurgical Products. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on key recent developments.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Global Markets Direct’s team of industry experts.

Scope

- Market size and company share data for Neurology Devices market categories – Neurostimulation Devices, Neurological Diagnostic Equipment, Interventional Neurology, CSF Management and Neurosurgical Products.
- Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within five market categories. Data from 2003 to 2010, forecast forward for 7 years to 2017.
- 2010 company shares and distribution shares data for each of the five market categories.
- Global corporate-level profiles of key companies operating within the Egypt Neurology Devices market.
- Key players covered include Nihon Kohden Corporation, Medtronic, Inc., B. Braun Melsungen AG, Boston Scientific Corporation, Terumo Corporation, KARL STORZ GmbH & Co. KG and others.

Reasons to buy

- Develop business strategies by identifying the key market categories and segments poised for strong growth.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the Egypt Neurology Devices competitive landscape.
- Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.

1
1

1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What is This Report About?
3 Neurology Devices In Egypt
3.1 Neurology Devices, Egypt, Overall Revenue ($m), 2003-2017
3.2 Neurology Devices, Egypt, Category Volume (Units), 2003-2017
3.3 Neurology Devices, Egypt, Company Share (2009-2010)
4 CSF Management In Egypt
4.1 CSF Management Overall Revenue (2003-2017)
4.2 CSF Management Overall Volume (2003-2017)
4.3 CSF Management Average Price (2003-2017)
4.4 CSF Management Distribution Share (2009-2010)
4.5 CSF Management, Egypt, Company Share (2009-2010)
5 Interventional Neurology In Egypt
5.1 Interventional Neurology Overall Revenue (2003-2017)
5.1.1 Embolic Systems Revenue (2003-2017)
5.1.2 Navigational Systems Revenue (2003-2017)
5.2 Interventional Neurology Overall Volume (2003-2017)
5.2.1 Embolic Systems Volume (2003-2017)
5.2.2 Navigational Systems Volume (2003-2017)
5.3 Interventional Neurology Average Price (2003-2017)
5.4 Interventional Neurology Distribution Share (2009-2010)
5.5 Interventional Neurology, Egypt, Company Share (2009-2010)
6 Neurological Diagnostic Equipment In Egypt
6.1 Neurological Diagnostic Equipment Overall Revenue (2003-2017)
6.2 Neurological Diagnostic Equipment Overall Volume (2003-2017)
6.3 Neurological Diagnostic Equipment Average Price (2003-2017)
6.4 Neurological Diagnostic Equipment Distribution Share (2009-2010)
6.5 Neurological Diagnostic Equipment, Egypt, Company Share (2009-2010)
7 Neurostimulation Devices In Egypt
7.1 Neurostimulation Devices Overall Revenue (2003-2017)
7.2 Neurostimulation Devices Overall Volume (2003-2017)
7.3 Neurostimulation Devices Average Price (2003-2017)
7.4 Neurostimulation Devices Distribution Share (2009-2010)
7.5 Neurostimulation Devices, Egypt, Company Share (2009-2010)
8 Neurosurgical Products In Egypt
8.1 Neurosurgical Products Overall Revenue (2003-2017)
8.2 Neurosurgical Products Overall Volume (2003-2017)
8.3 Neurosurgical Products Average Price (2003-2017)
8.4 Neurosurgical Products Distribution Share (2009-2010)
8.5 Neurosurgical Products, Egypt, Company Share (2009-2010)
9 Radiosurgery In Egypt
9.1 Radiosurgery Overall Revenue (2003-2007)
9.2 Radiosurgery Overall Volume (2003-2007)
9.3 Radiosurgery Average Price (2003-2007)
10 Overview of Key Companies in Egypt Neurology Devices Market
10.1 Nihon Kohden Corporation
10.1.1 Company Overview
10.2 Medtronic, Inc.
10.2.1 Company Overview
10.3 B. Braun Melsungen AG
10.3.1 Company Overview
10.4 Boston Scientific Corporation
10.4.1 Company Overview
10.5 Terumo Corporation
10.5.1 Company Overview
10.6 KARL STORZ GmbH & Co. KG
10.6.1 Company Overview
10.7 St. Jude Medical, Inc.
10.7.1 Company Overview
10.8 DePuy, Inc.
10.8.1 Company Overview
10.9 Covidien plc
10.9.1 Company Overview
10.10 Natus Medical Incorporated
10.10.1 Company Overview
10.11 Integra LifeSciences Holdings Corporation
10.11.1 Company Overview
10.12 CareFusion Corporation
10.12.1 Company Overview
10.13 Cyberonics, Inc.
10.13.1 Company Overview
10.14 ev3 Inc.
10.14.1 Company Overview
10.15 Sophysa S.A.
10.15.1 Company Overview
11 Appendix
11.1 Global Markets Direct Research Methodology
11.2 Definitions of Markets Covered in the Report
11.2.1 Neurology Devices
11.3 Secondary Research
11.4 Primary Research
11.5 Models
11.6 Forecasts
11.7 Expert Panel Validation
11.8 Currency Conversion
11.9 Contact Us
11.10 Disclaimer

1.1 List of Tables
Table 1: Neurology Devices, Egypt, Overall Revenue ($m), 2003-2017
Table 2: Neurology Devices, Egypt, Overall Revenue ($m), Historic, 2003-2010
Table 3: Neurology Devices, Egypt, Overall Revenue ($m), Forecast, 2010-2017
Table 4: Neurology Devices, Egypt, Category Volume (Units), 2003-2017
Table 5: Neurology Devices, Egypt, Category Volume (Units), Historic, 2003-2010
Table 6: Neurology Devices, Egypt, Category Volume (Units), Forecast, 2010-2017
Table 7: Neurology Devices, Egypt, Company Share by Revenue ($m), 2009-2010
Table 8: CSF Management, Egypt, Revenue ($m) by Segment, Historic, 2003-2010
Table 9: CSF Management, Egypt, Revenue ($m) by Segment, Forecast, 2010-2017
Table 10: CSF Management, Egypt, Volume (Units) by Segment, Historic, 2003-2010
Table 11: CSF Management, Egypt, Volume (Units) by Segment, Forecast, 2010-2017
Table 12: CSF Management, Egypt, Average Price ($), Historic, 2003-2010
Table 13: CSF Management, Egypt, Average Price ($), Forecast, 2010-2017
Table 14: CSF Management, Egypt, Distribution Share by Revenue ($m), 2009-2010
Table 15: CSF Management, Egypt, Company Share by Revenue ($m), 2009-2010
Table 16: Interventional Neurology, Egypt, Revenue ($m) by Segment, Historic, 2003-2010
Table 17: Interventional Neurology, Egypt, Revenue ($m) by Segment, Forecast, 2010-2017
Table 18: Embolic Systems, Egypt, Revenue ($m) by Sub-Segment, Historic, 2003-2010
Table 19: Embolic Systems, Egypt, Revenue ($m) by Sub-Segment, Forecast, 2010-2017
Table 20: Navigational Systems, Egypt, Revenue ($m) by Sub-Segment, Historic, 2003-2010
Table 21: Navigational Systems, Egypt, Revenue ($m) by Sub-Segment, Forecast, 2010-2017
Table 22: Interventional Neurology, Egypt, Volume (Units) by Segment, Historic, 2003-2010
Table 23: Interventional Neurology, Egypt, Volume (Units) by Segment, Forecast, 2010-2017
Table 24: Embolic Systems, Egypt, Volume (Units) by Sub-Segment, Historic, 2003-2010
Table 25: Embolic Systems, Egypt, Volume (Units) by Sub-Segment, Forecast, 2010-2017
Table 26: Navigational Systems, Egypt, Volume (Units) by Sub-Segment, Historic, 2003-2010
Table 27: Navigational Systems, Egypt, Volume (Units) by Sub-Segment, Forecast, 2010-2017
Table 28: Interventional Neurology, Egypt, Average Price ($), Historic, 2003-2010
Table 29: Interventional Neurology, Egypt, Average Price ($), Forecast, 2010-2017
Table 30: Interventional Neurology, Egypt, Distribution Share by Revenue ($m), 2009-2010
Table 31: Interventional Neurology, Egypt, Company Share by Revenue ($m), 2009-2010
Table 32: Neurological Diagnostic Equipment, Egypt, Revenue ($m) by Segment, Historic, 2003-2010
Table 33: Neurological Diagnostic Equipment, Egypt, Revenue ($m) by Segment, Forecast, 2010-2017
Table 34: Neurological Diagnostic Equipment, Egypt, Volume (Units) by Segment, Historic, 2003-2010
Table 35: Neurological Diagnostic Equipment, Egypt, Volume (Units) by Segment, Forecast, 2010-2017
Table 36: Neurological Diagnostic Equipment, Egypt, Average Price ($), Historic, 2003-2010
Table 37: Neurological Diagnostic Equipment, Egypt, Average Price ($), Forecast, 2010-2017
Table 38: Neurological Diagnostic Equipment, Egypt, Distribution Share by Revenue ($m), 2009-2010
Table 39: Neurological Diagnostic Equipment, Egypt, Company Share by Revenue ($m), 2009-2010
Table 40: Neurostimulation Devices, Egypt, Revenue ($m) by Segment, Historic, 2003-2010
Table 41: Neurostimulation Devices, Egypt, Revenue ($m) by Segment, Forecast, 2010-2017
Table 42: Neurostimulation Devices, Egypt, Volume (Units) by Segment, Historic, 2003-2010
Table 43: Neurostimulation Devices, Egypt, Volume (Units) by Segment, Forecast, 2010-2017
Table 44: Neurostimulation Devices, Egypt, Average Price ($), Historic, 2003-2010
Table 45: Neurostimulation Devices, Egypt, Average Price ($), Forecast, 2010-2017
Table 46: Neurostimulation Devices, Egypt, Distribution Share by Revenue ($m), 2009-2010
Table 47: Neurostimulation Devices, Egypt, Company Share by Revenue ($m), 2009-2010
Table 48: Neurosurgical Products, Egypt, Revenue ($m) by Segment, Historic, 2003-2010
Table 49: Neurosurgical Products, Egypt, Revenue ($m) by Segment, Forecast, 2010-2017
Table 50: Neurosurgical Products, Egypt, Volume (Units) by Segment, Historic, 2003-2010
Table 51: Neurosurgical Products, Egypt, Volume (Units) by Segment, Forecast, 2010-2017
Table 52: Neurosurgical Products, Egypt, Average Price ($), Historic, 2003-2010
Table 53: Neurosurgical Products, Egypt, Average Price ($), Forecast, 2010-2017
Table 54: Neurosurgical Products, Egypt, Distribution Share by Revenue ($m), 2009-2010
Table 55: Neurosurgical Products, Egypt, Company Share by Revenue ($m), 2009-2010
Table 56: Radiosurgery, Egypt, Revenue ($m), Historic, 2003-2007
Table 57: Radiosurgery, Egypt, Volume (Units) by Segment, Historic, 2003-2007
Table 58: Radiosurgery, Egypt, Average Price ($), Historic, 2003-2007
Table 59: USD to Local Currency, Egypt, Average Actual Rate 2003-2010

1.2 List of Figures
Figure 1: Neurology Devices, Egypt, Overall Revenue ($m), 2003-2017
Figure 2: Neurology Devices, Egypt, Overall Revenue ($m), Historic, 2003-2010
Figure 3: Neurology Devices, Egypt, Overall Revenue ($m), Forecast, 2010-2017
Figure 4: Neurology Devices, Egypt, Category Volume (Units), 2003-2017
Figure 5: Neurology Devices, Egypt, Category Volume (Units), Historic, 2003-2010
Figure 6: Neurology Devices, Egypt, Category Volume (Units), Forecast, 2010-2017
Figure 7: Neurology Devices, Egypt, Company Share (%), 2010
Figure 8: CSF Management, Egypt, Revenue ($m) by Segment, Historic, 2003-2010
Figure 9: CSF Management, Egypt, Revenue ($m) by Segment, Forecast, 2010-2017
Figure 10: CSF Management, Egypt, Volume (Units) by Segment, Historic, 2003-2010
Figure 11: CSF Management, Egypt, Volume (Units) by Segment, Forecast, 2010-2017
Figure 12: CSF Management, Egypt, Company Share (%), 2010
Figure 13: Interventional Neurology, Egypt, Revenue ($m) by Segment, Historic, 2003-2010
Figure 14: Interventional Neurology, Egypt, Revenue ($m) by Segment, Forecast, 2010-2017
Figure 15: Embolic Systems, Egypt, Revenue ($m) by Sub-Segment, Historic, 2003-2010
Figure 16: Embolic Systems, Egypt, Revenue ($m) by Sub-Segment, Forecast, 2010-2017
Figure 17: Navigational Systems, Egypt, Revenue ($m) by Sub-Segment, Historic, 2003-2010
Figure 18: Navigational Systems, Egypt, Revenue ($m) by Sub-Segment, Forecast, 2010-2017
Figure 19: Interventional Neurology, Egypt, Volume (Units) by Segment, Historic, 2003-2010
Figure 20: Interventional Neurology, Egypt, Volume (Units) by Segment, Forecast, 2010-2017
Figure 21: Embolic Systems, Egypt, Volume (Units) by Sub-Segment, Historic, 2003-2010
Figure 22: Embolic Systems, Egypt, Volume (Units) by Sub-Segment, Forecast, 2010-2017
Figure 23: Navigational Systems, Egypt, Volume (Units) by Sub-Segment, Historic, 2003-2010
Figure 24: Navigational Systems, Egypt, Volume (Units) by Sub-Segment, Forecast, 2010-2017
Figure 25: Interventional Neurology, Egypt, Company Share (%), 2010
Figure 26: Neurological Diagnostic Equipment, Egypt, Revenue ($m) by Segment, Historic, 2003-2010
Figure 27: Neurological Diagnostic Equipment, Egypt, Revenue ($m) by Segment, Forecast, 2010-2017
Figure 28: Neurological Diagnostic Equipment, Egypt, Volume (Units) by Segment, Historic, 2003-2010
Figure 29: Neurological Diagnostic Equipment, Egypt, Volume (Units) by Segment, Forecast, 2010-2017
Figure 30: Neurological Diagnostic Equipment, Egypt, Company Share (%), 2010
Figure 31: Neurostimulation Devices, Egypt, Revenue ($m) by Segment, Historic, 2003-2010
Figure 32: Neurostimulation Devices, Egypt, Revenue ($m) by Segment, Forecast, 2010-2017
Figure 33: Neurostimulation Devices, Egypt, Volume (Units) by Segment, Historic, 2003-2010
Figure 34: Neurostimulation Devices, Egypt, Volume (Units) by Segment, Forecast, 2010-2017
Figure 35: Neurostimulation Devices, Egypt, Company Share (%), 2010
Figure 36: Neurosurgical Products, Egypt, Revenue ($m) by Segment, Historic, 2003-2010
Figure 37: Neurosurgical Products, Egypt, Revenue ($m) by Segment, Forecast, 2010-2017
Figure 38: Neurosurgical Products, Egypt, Volume (Units) by Segment, Historic, 2003-2010
Figure 39: Neurosurgical Products, Egypt, Volume (Units) by Segment, Forecast, 2010-2017
Figure 40: Neurosurgical Products, Egypt, Company Share (%), 2010
Figure 41: Radiosurgery, Egypt, Revenue ($m), Historic, 2003-2007
Figure 42: Radiosurgery, Egypt, Volume (Units) by Segment, Historic, 2003-2007
Figure 43: Global Markets Direct Methodology

Nihon Kohden Corporation
Medtronic, Inc.
B. Braun Melsungen AG
Boston Scientific Corporation
Terumo Corporation
KARL STORZ GmbH & Co. KG
St. Jude Medical, Inc.
DePuy, Inc.
Covidien plc
Natus Medical Incorporated
Integra LifeSciences Holdings Corporation
CareFusion Corporation
Cyberonics, Inc.
ev3 Inc.
Sophysa S.A.

Customers who bought this item also bought

• Egypt Diagnostic Imaging Investment Opportunities, Analysis and Forecasts to 2017
• Egypt In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2017
• Middle East And Africa Neurology Devices Market Outlook to 2017
• Egypt Diagnostic Imaging Investment Opportunities, Analysis and Forecasts to 2018
• Egypt In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2018
• Neurology Devices Market Outlook in South Africa to 2017 - Neurostimulation Devices, Interventional Neurology and Others
• Neurology Devices Market Outlook in Israel to 2017 - Neurostimulation Devices, Interventional Neurology and Others
• Neurology Devices Market Outlook in Saudi Arabia to 2017 - Neurostimulation Devices, Interventional Neurology and Other
• Economic 360 for Egypt: Growth Prospects and Emerging Opportunities in the Healthcare Industry
• Neurology Devices Market Outlook in Taiwan to 2017 - Neurostimulation Devices, Interventional Neurology and Other